AEMD AETHLON MEDICAL INC
Price Chart
Executive Summary
Aethlon Medical filed an 8-K and a 424B5 prospectus supplement to update the amount of common stock it may sell under its existing ATM agreement with H.C. Wainwright. Following the amendment, the company may offer up to $542,716 in additional shares, on top of $1,849,457 already sold. The filing is a routine administrative update to comply with Form S-3's public float limitations.
Actionable Insight
The ATM facility represents ongoing dilution risk for a micro-cap stock with a $3M market cap. The company has already sold $1.85M in shares this period and can sell another $543K. Monitor for actual sales via daily volume and subsequent 8-K filings. The stock's low price ($3.07) and small float make it susceptible to further downward pressure from ATM sales.
Key Facts
- Aethlon filed Amendment No. 1 to its ATM prospectus supplement on June 4, 2026.
- The company may now offer up to $542,716 in common stock under the ATM agreement.
- Previously, $1,849,457 in shares had already been sold under the same prospectus supplement.
- As of June 1, 2026, Aethlon had 2,344,886 shares outstanding, with a public float of 2,337,629 shares.
- The aggregate market value of the public float was $7,176,521 as of May 27, 2026, based on a $3.07 share price.
- The offering is limited by General Instruction I.B.6 of Form S-3 to one-third of public float in any 12-month period.
- The company's market cap is approximately $3 million, and analyst consensus is 0% bullish.
Financial Impact
Up to $542,716 in additional common stock may be sold via ATM, representing ~18% of current market cap. Combined with $1,849,457 already sold, total potential ATM sales in the current 12-month period are $2,392,173.
Risk Factors
- Continued dilution from ATM sales could pressure the stock price.
- The company's small market cap ($3M) and low public float make it vulnerable to selling pressure.
- Analyst consensus is heavily bearish (0% bullish), indicating limited institutional support.
Market Snapshot
Documents Analyzed
This report is based on 9 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (AEMD) — Batch item 1 | 0001683168-26-004540 |
| Document: aethlon_ex0501.htm | 0001683168-26-004539 |
| Document: 0001683168-26-004540-index-headers.html | 0001683168-26-004540 |
| Document: 0001683168-26-004540-index.html | 0001683168-26-004540 |
| Document: 0001683168-26-004540.txt | 0001683168-26-004540 |
| 424B5 Filing (AEMD) — Batch item 6 | 0001683168-26-004539 |
| Document: 0001683168-26-004539-index-headers.html | 0001683168-26-004540 |
| Document: 0001683168-26-004539-index.html | 0001683168-26-004540 |
| Document: 0001683168-26-004539.txt | 0001683168-26-004540 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 10, 2026
2d ago
|
8-K
| $2.03 awaiting T+1 | awaiting T+1 | — | $2.02 (−0.49%) |
|
Jun 4, 2026
8d ago
|
8-K / 424B5
| $2.13 $1.91 | ▲ +10.33% | ▲ +7.73% | $2.02 (+5.16%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access